Immunovant Stock Technical Analysis

IMVT -  USA Stock  

USD 8.53  0.28  3.18%

As of the 20th of October, Immunovant retains the market risk adjusted performance of (0.017742), and Risk Adjusted Performance of 0.0067. Immunovant technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Immunovant, which can be compared to its competitors. Please check out Immunovant coefficient of variation, maximum drawdown, as well as the relationship between the Maximum Drawdown and skewness to decide if Immunovant is priced fairly, providing market reflects its last-minute price of 8.53 per share. Given that Immunovant has jensen alpha of (0.06), we strongly advise you to confirm Immunovant's regular market performance to make sure the company can sustain itself at a future point.

Immunovant Technical Analysis 

 
Refresh

Immunovant Analyst Consensus

Target PriceAdvice# of Analysts
22.86Buy7Odds
Immunovant current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Immunovant analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Immunovant stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Immunovant, talking to its executives and customers, or listening to Immunovant conference calls.
Immunovant Analyst Advice Details
Immunovant technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Immunovant technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Immunovant trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Immunovant Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Immunovant volatility. High ATR values indicate high volatility, and low values indicate low volatility. View also all equity analysis or get more info about average true range volatility indicators indicator.

Immunovant Trend Analysis

Use this graph to draw trend lines for Immunovant. You can use it to identify possible trend reversals for Immunovant as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Immunovant price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Immunovant Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Immunovant applied against its price change over selected period. The best fit line has a slop of   0.00864  , which means Immunovant will continue generating value for investors. It has 122 observation points and a regression sum of squares at 2.82, which is the sum of squared deviations for the predicted Immunovant price change compared to its average price change.

About Immunovant Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Immunovant on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Immunovant based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Immunovant stock first instead of the macroeconomic environment surrounding Immunovant. By analyzing Immunovant's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Immunovant's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Immunovant specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2010 2019 2020 2021 (projected)
Current Ratio1.947.1221.7917.42
Book Value per Share0.332.184.463.69

Immunovant October 20, 2021 Technical Indicators

Most technical analysis of Immunovant help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Immunovant from various momentum indicators to cycle indicators. When you analyze Immunovant charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Immunovant October 20, 2021 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Immunovant stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Please see Risk vs Return Analysis. Note that the Immunovant information on this page should be used as a complementary analysis to other Immunovant's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Complementary Tools for Immunovant Stock analysis

When running Immunovant price analysis, check to measure Immunovant's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunovant is operating at the current time. Most of Immunovant's value examination focuses on studying past and present price action to predict the probability of Immunovant's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immunovant's price. Additionally, you may evaluate how the addition of Immunovant to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
The market value of Immunovant is measured differently than its book value, which is the value of Immunovant that is recorded on the company's balance sheet. Investors also form their own opinion of Immunovant's value that differs from its market value or its book value, called intrinsic value, which is Immunovant's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunovant's market value can be influenced by many factors that don't directly affect Immunovant underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunovant's value and its price as these two are different measures arrived at by different means. Investors typically determine Immunovant value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunovant's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.